By Topic

Reliability in deep brain stimulation

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

2 Author(s)
H. A. Shill ; Med. Center, Barrow Neurological Inst., Phoenix, AZ, USA ; A. G. Shetter

Neurostimulation has been used successfully for disabling tremor disorders and Parkinson's disease. Electrodes are implanted into the deep brain structures with leads extending down to the chest and connecting to the programming hardware and battery source (implantable pulse generator). The only currently U.S. Food and Drug Administration (FDA)-approved treatment of this type is the Activa Therapy from Medtronic, Inc., now in the US market since 1997 and available worldwide. Reliability issues pertaining to the design, manufacturing, and clinical use of this device, with attention paid primarily to those issues unique to implantation and use in humans, will be reviewed.

Published in:

IEEE Transactions on Device and Materials Reliability  (Volume:5 ,  Issue: 3 )